Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Revitalizing systemic immune responses in advanced NSCLC using FLT3L and SBRT
Divij Mathew, Nitin Ohri, Shin Foong Ngiow, et al.
Cell
|
December 3, 2016
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L Benci, Bihui Xu, Yu Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2020
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration
Yolanda D Tseng, Bradford S Hoppe, Katerina Dedeckova, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
British Journal of Cancer
|
October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Amit Maity, Rosemarie Mick, Alexander C Huang, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study
Steven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
JAMA Dermatology
|
October 28, 2020
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis
Joseph S Durgin, Neha N Jariwala, Maria Wysocka, et al.
The Journal of Clinical Investigation
|
November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
Lori S Hart, John T Cunningham, Tatini Datta, et al.
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone
Ioannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 29, 2025
FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone
Ioannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Revitalizing systemic immune responses in advanced NSCLC using FLT3L and SBRT
Divij Mathew, Nitin Ohri, Shin Foong Ngiow, et al.
Cell
|
December 3, 2016
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L Benci, Bihui Xu, Yu Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2020
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration
Yolanda D Tseng, Bradford S Hoppe, Katerina Dedeckova, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
British Journal of Cancer
|
October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Amit Maity, Rosemarie Mick, Alexander C Huang, et al.
Journal for Immunotherapy of Cancer
|
July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study
Steven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
JAMA Dermatology
|
October 28, 2020
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis
Joseph S Durgin, Neha N Jariwala, Maria Wysocka, et al.
The Journal of Clinical Investigation
|
November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
Lori S Hart, John T Cunningham, Tatini Datta, et al.
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone
Ioannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 29, 2025
FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone
Ioannis I Verginadis, Anastasia Velalopoulou, Michele M Kim, et al.
Page
of 12